Galactose and glucose metabolism in galactokinase deficient, galactose-1-P-uridyl transferase deficient and normal human fibroblasts.
Despite the genetic interruption of the Leloir pathway both galactosemic patients and galactosemic fibroblasts can convert galactose to CO2 and TCA precipitable products, although at less than the normal rate. These observations stimulated investigations into the identity of the alternative metabolic routes which allows for galactose metabolism in the absence of in vitro galactose-1-P-uridyl transferase. Four lines of galactosemic cells, each without detectable gal-transferase, produced 14CO2 from [1-14C]-galactose (0.094 mumoles in 20 cc of medium) at approximately 39% +/- 16% the rate of transferase positive cells over a 48-hour period. However, galactokinase deficient fibroblasts produced 14CO2 and TCA precipitable products from [1-14C]-galactose or [U-14C]-galactose at only 3% to 9% the rate of normal fibroblasts. Therefore it seems likely that gal-transferase deficient fibroblasts must first synthesize galactose-1-P for further metabolism of galactose.
D000328:Adult; D001671:Biochemistry / Q000379:methods; D002239:Carbohydrate Metabolism, Inborn Errors / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D002245:Carbon Dioxide / Q000096:biosynthesis; D002460:Cell Line; D002648:Child; D002675:Child, Preschool; D005260:Female; D005347:Fibroblasts / Q000201:enzymology / Q000378:metabolism*; D005690:Galactose / Q000378:metabolism*; D005693:Galactosemias / Q000378:metabolism* / Q000473:pathology; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D009713:Nucleotidyltransferases; D010641:Phenotype; D010770:Phosphotransferases; D005694:UTP-Hexose-1-Phosphate Uridylyltransferase / Q000172:deficiency
D002245:Carbon Dioxide; D010770:Phosphotransferases; D009713:Nucleotidyltransferases; D005694:UTP-Hexose-1-Phosphate Uridylyltransferase; D005947:Glucose; D005690:Galactose